FHIR Osiris Implementation Guide
1.1.0 - trial-implementation

Publication Build: This will be filled in by the publication tooling

## ValueSet: Morphology Value Set

Official URL: https://ig-osiris.cancer.fr/ig/osiris/ValueSet/Morphology | Version: 1.1.0
Draft as of 2025-04-03 | Computable Name: Morphology

Cancer morphology

References

- Tumor Pathology Event

### Logical Definition (CLD)

Generated Narrative: ValueSet Morphology

- Include ces codes sont définis dans `http://terminology.hl7.org/CodeSystem/icd-o-3`

  Code | Display
  8000/0 | Neoplasm, benign
  8000/1 | Neoplasm, uncertain whether benign or malignant
  8000/3 | Neoplasm, malignant
  8000/6 | Neoplasm, metastatic
  8000/9 | Neoplasm, malignant, uncertain whether primary or metastatic
  8001/0 | Tumor cells, benign
  8001/1 | Tumor cells, uncertain whether benign or malignant
  8001/3 | Tumor cells, malignant
  8002/3 | Malignant tumor, small cell type
  8003/3 | Malignant tumor, giant cell type
  8004/3 | Malignant tumor, spindle cell type
  8005/0 | Clear cell tumor, NOS
  8005/3 | Malignant tumor, clear cell type
  8010/0 | Epithelial tumor, benign
  8010/2 | Carcinoma in situ, NOS
  8010/3 | Carcinoma, NOS
  8010/6 | Carcinoma, metastatic, NOS
  8010/9 | Carcinomatosis
  8011/0 | Epithelioma, benign
  8011/3 | Epithelioma, malignant
  8012/3 | Large cell carcinoma, NOS
  8013/3 | Large cell neuroendocrine carcinoma
  8014/3 | Large cell carcinoma with rhabdoid phenotype
  8015/3 | Glassy cell carcinoma
  8020/3 | Carcinoma, undifferentiated, NOS
  8021/3 | Carcinoma, anaplastic, NOS
  8022/3 | Pleomorphic carcinoma
  8030/3 | Giant cell and spindle cell carcinoma
  8031/3 | Giant cell carcinoma
  8032/3 | Spindle cell carcinoma, NOS
  8033/3 | Pseudosarcomatous carcinoma
  8034/3 | Polygonal cell carcinoma
  8035/3 | Carcinoma with osteoclast-like giant cells
  8040/0 | Tumorlet, benign
  8040/1 | Tumorlet, NOS
  8041/3 | Small cell carcinoma, NOS
  8042/3 | Oat cell carcinoma
  8043/3 | Small cell carcinoma, fusiform cell
  8044/3 | Small cell carcinoma, intermediate cell
  8045/3 | Combined small cell carcinoma
  8046/3 | Non-small cell carcinoma
  8050/0 | Papilloma, NOS
  8050/2 | Papillary carcinoma in situ
  8050/3 | Papillary carcinoma, NOS
  8051/0 | Verrucous papilloma
  8051/3 | Verrucous carcinoma, NOS
  8052/0 | Squamous cell papilloma, NOS
  8052/2 | Papillary squamous cell carcinoma, non-invasive
  8052/3 | Papillary squamous cell carcinoma
  8053/0 | Squamous cell papilloma, inverted
  8060/0 | Squamous papillomatosis
  8070/2 | Squamous cell carcinoma in situ, NOS
  8070/3 | Squamous cell carcinoma, NOS
  8070/6 | Squamous cell carcinoma, metastatic, NOS
  8071/3 | Squamous cell carcinoma, keratinizing, NOS
  8072/3 | Squamous cell carcinoma, large cell, nonkeratinizing, NOS
  8073/3 | Squamous cell carcinoma, small cell, nonkeratinizing
  8074/3 | Squamous cell carcinoma, spindle cell
  8075/3 | Squamous cell carcinoma, adenoid
  8076/2 | Squamous cell carcinoma in situ with questionable stromal invasion
  8076/3 | Squamous cell carcinoma, microinvasive
  8077/2 | Squamous intraepithelial neoplasia, grade III
  8078/3 | Squamous cell carcinoma with horn formation
  8080/2 | Queyrat erythroplasia
  8081/2 | Bowen disease
  8082/3 | Lymphoepithelial carcinoma
  8083/3 | Basaloid squamous cell carcinoma
  8084/3 | Squamous cell carcinoma, clear cell type
  8090/1 | Basal cell tumor
  8090/3 | Basal cell carcinoma, NOS
  8091/3 | Multifocal superficial basal cell carcinoma
  8092/3 | Infiltrating basal cell carcinoma, NOS
  8093/3 | Basal cell carcinoma, fibroepithelial
  8094/3 | Basosquamous carcinoma
  8095/3 | Metatypical carcinoma
  8096/0 | Intraepidermal epithelioma of Jadassohn
  8097/3 | Basal cell carcinoma, nodular
  8098/3 | Adenoid basal carcinoma
  8100/0 | Trichoepithelioma
  8101/0 | Trichofolliculoma
  8102/0 | Trichilemmoma
  8102/3 | Trichilemmocarcinoma
  8103/0 | Pilar tumor
  8110/0 | Pilomatrixoma, NOS
  8110/3 | Pilomatrix carcinoma
  8120/0 | Transitional cell papilloma, benign
  8120/1 | Urothelial papilloma, NOS
  8120/2 | Transitional cell carcinoma in situ
  8120/3 | Transitional cell carcinoma, NOS
  8121/0 | Schneiderian papilloma, NOS
  8121/1 | Transitional cell papilloma, inverted, NOS
  8121/3 | Schneiderian carcinoma
  8122/3 | Transitional cell carcinoma, spindle cell
  8123/3 | Basaloid carcinoma
  8124/3 | Cloacogenic carcinoma
  8130/1 | Papillary transitional cell neoplasm of low malignant potential
  8130/2 | Papillary transitional cell carcinoma, non-invasive
  8130/3 | Papillary transitional cell carcinoma
  8131/3 | Transitional cell carcinoma, micropapillary
  8140/0 | Adenoma, NOS
  8140/1 | Atypical adenoma
  8140/2 | Adenocarcinoma in situ, NOS
  8140/3 | Adenocarcinoma, NOS
  8140/6 | Adenocarcinoma, metastatic, NOS
  8141/3 | Scirrhous adenocarcinoma
  8142/3 | Linitis plastica
  8143/3 | Superficial spreading adenocarcinoma
  8144/3 | Adenocarcinoma, intestinal type
  8145/3 | Carcinoma, diffuse type
  8146/0 | Monomorphic adenoma
  8147/0 | Basal cell adenoma
  8147/3 | Basal cell adenocarcinoma
  8148/2 | Glandular intraepithelial neoplasia, grade III
  8149/0 | Canalicular adenoma
  8150/0 | Islet cell adenoma
  8150/1 | Islet cell tumor, NOS
  8150/3 | Islet cell carcinoma
  8151/0 | Insulinoma, NOS
  8151/3 | Insulinoma, malignant
  8152/1 | Glucagonoma, NOS
  8152/3 | Glucagonoma, malignant
  8153/1 | Gastrinoma, NOS
  8153/3 | Gastrinoma, malignant
  8154/3 | Mixed islet cell and exocrine adenocarcinoma
  8155/1 | Vipoma, NOS
  8155/3 | Vipoma, malignant
  8156/1 | Somatostatinoma, NOS
  8156/3 | Somatostatinoma, malignant
  8157/1 | Enteroglucagonoma, NOS
  8157/3 | Enteroglucagonoma, malignant
  8160/0 | Bile duct adenoma
  8160/3 | Cholangiocarcinoma
  8161/0 | Bile duct cystadenoma
  8161/3 | Bile duct cystadenocarcinoma
  8162/3 | Klatskin tumor
  8170/0 | Liver cell adenoma
  8170/3 | Hepatocellular carcinoma, NOS
  8171/3 | Hepatocellular carcinoma, fibrolamellar
  8172/3 | Hepatocellular carcinoma, scirrhous
  8173/3 | Hepatocellular carcinoma, spindle cell variant
  8174/3 | Hepatocellular carcinoma, clear cell type
  8175/3 | Hepatocellular carcinoma, pleomorphic type
  8180/3 | Combined hepatocellular carcinoma and cholangiocarcinoma
  8190/0 | Trabecular adenoma
  8190/3 | Trabecular adenocarcinoma
  8191/0 | Embryonal adenoma
  8200/0 | Eccrine dermal cylindroma
  8200/3 | Adenoid cystic carcinoma
  8201/2 | Cribriform carcinoma in situ
  8201/3 | Cribriform carcinoma, NOS
  8202/0 | Microcystic adenoma
  8204/0 | Lactating adenoma
  8210/0 | Adenomatous polyp, NOS
  8210/2 | Adenocarcinoma in situ in adenomatous polyp
  8210/3 | Adenocarcinoma in adenomatous polyp
  8211/0 | Tubular adenoma, NOS
  8211/3 | Tubular adenocarcinoma
  8212/0 | Flat adenoma
  8213/0 | Serrated adenoma
  8214/3 | Parietal cell carcinoma
  8215/3 | Adenocarcinoma of anal glands
  8220/0 | Adenomatous polyposis coli
  8220/3 | Adenocarcinoma in adenomatous polyposis coli
  8221/0 | Multiple adenomatous polyps
  8221/3 | Adenocarcinoma in multiple adenomatous polyps
  8230/2 | Ductal carcinoma in situ, solid type
  8230/3 | Solid carcinoma, NOS
  8231/3 | Carcinoma simplex
  8240/1 | Carcinoid tumor of uncertain malignant potential
  8240/3 | Carcinoid tumor, NOS
  8241/3 | Enterochromaffin cell carcinoid
  8242/1 | Enterochromaffin-like cell carcinoid, NOS
  8242/3 | Enterochromaffin-like cell tumor, malignant
  8243/3 | Goblet cell carcinoid
  8244/3 | Composite carcinoid
  8245/1 | Tubular carcinoid
  8245/3 | Adenocarcinoid tumor
  8246/3 | Neuroendocrine carcinoma, NOS
  8247/3 | Merkel cell carcinoma
  8248/1 | Apudoma
  8249/3 | Atypical carcinoid tumor
  8250/1 | Pulmonary adenomatosis
  8250/3 | Bronchiolo-alveolar adenocarcinoma, NOS
  8251/0 | Alveolar adenoma
  8251/3 | Alveolar adenocarcinoma
  8252/3 | Bronchiolo-alveolar carcinoma, non- mucinous
  8253/3 | Bronchiolo-alveolar carcinoma, mucinous
  8254/3 | Bronchiolo-alveolar carcinoma, mixed mucinous and non-mucinous
  8255/3 | Adenocarcinoma with mixed subtypes
  8260/0 | Papillary adenoma, NOS
  8260/3 | Papillary adenocarcinoma, NOS
  8261/0 | Villous adenoma, NOS
  8261/2 | Adenocarcinoma in situ in villous adenoma
  8261/3 | Adenocarcinoma in villous adenoma
  8262/3 | Villous adenocarcinoma
  8263/0 | Tubulovillous adenoma, NOS
  8263/2 | Adenocarcinoma in situ in tubulovillous adenoma
  8263/3 | Adenocarcinoma in tubulovillous adenoma
  8264/0 | Papillomatosis, glandular
  8270/0 | Chromophobe adenoma
  8270/3 | Chromophobe carcinoma
  8271/0 | Prolactinoma
  8272/0 | Pituitary adenoma, NOS
  8272/3 | Pituitary carcinoma, NOS
  8280/0 | Acidophil adenoma
  8280/3 | Acidophil carcinoma
  8281/0 | Mixed acidophil-basophil adenoma
  8281/3 | Mixed acidophil-basophil carcinoma
  8290/0 | Oxyphilic adenoma
  8290/3 | Oxyphilic adenocarcinoma
  8300/0 | Basophil adenoma
  8300/3 | Basophil carcinoma
  8310/0 | Clear cell adenoma
  8310/3 | Clear cell adenocarcinoma, NOS
  8311/1 | Hypernephroid tumor
  8312/3 | Renal cell carcinoma, NOS
  8313/0 | Clear cell adenofibroma
  8313/1 | Clear cell adenofibroma of borderline malignancy
  8313/3 | Clear cell adenocarcinofibroma
  8314/3 | Lipid-rich carcinoma
  8315/3 | Glycogen-rich carcinoma
  8316/3 | Cyst-associated renal cell carcinoma
  8317/3 | Renal cell carcinoma, chromophobe type
  8318/3 | Renal cell carcinoma, sarcomatoid
  8319/3 | Collecting duct carcinoma
  8320/3 | Granular cell carcinoma
  8321/0 | Chief cell adenoma
  8322/0 | Water-clear cell adenoma
  8322/3 | Water-clear cell adenocarcinoma
  8323/0 | Mixed cell adenoma
  8323/3 | Mixed cell adenocarcinoma
  8324/0 | Lipoadenoma
  8325/0 | Metanephric adenoma
  8330/0 | Follicular adenoma
  8330/1 | Atypical follicular adenoma
  8330/3 | Follicular adenocarcinoma, NOS
  8331/3 | Follicular adenocarcinoma, well differentiated
  8332/3 | Follicular adenocarcinoma, trabecular
  8333/0 | Microfollicular adenoma, NOS
  8333/3 | Fetal adenocarcinoma
  8334/0 | Macrofollicular adenoma
  8335/3 | Follicular carcinoma, minimally invasive
  8336/0 | Hyalinizing trabecular adenoma
  8337/3 | Insular carcinoma
  8340/3 | Papillary carcinoma, follicular variant
  8341/3 | Papillary microcarcinoma
  8342/3 | Papillary carcinoma, oxyphilic cell
  8343/3 | Papillary carcinoma, encapsulated
  8344/3 | Papillary carcinoma, columnar cell
  8345/3 | Medullary carcinoma with amyloid stroma
  8346/3 | Mixed medullary-follicular carcinoma
  8347/3 | Mixed medullary-papillary carcinoma
  8350/3 | Nonencapsulated sclerosing carcinoma
  8360/1 | Multiple endocrine adenomas
  8361/0 | Juxtaglomerular tumor
  8370/0 | Adrenal cortical adenoma, NOS
  8370/3 | Adrenal cortical carcinoma
  8371/0 | Adrenal cortical adenoma, compact cell
  8372/0 | Adrenal cortical adenoma, pigmented
  8373/0 | Adrenal cortical adenoma, clear cell
  8374/0 | Adrenal cortical adenoma, glomerulosa cell
  8375/0 | Adrenal cortical adenoma, mixed cell
  8380/0 | Endometrioid adenoma, NOS
  8380/1 | Endometrioid adenoma, borderline malignancy
  8380/3 | Endometrioid adenocarcinoma, NOS
  8381/0 | Endometrioid adenofibroma, NOS
  8381/1 | Endometrioid adenofibroma, borderline malignancy
  8381/3 | Endometrioid adenofibroma, malignant
  8382/3 | Endometrioid adenocarcinoma, secretory variant
  8383/3 | Endometrioid adenocarcinoma, ciliated cell variant
  8384/3 | Adenocarcinoma, endocervical type
  8390/0 | Skin appendage adenoma
  8390/3 | Skin appendage carcinoma
  8391/0 | Follicular fibroma
  8392/0 | Syringofibroadenoma
  8400/0 | Sweat gland adenoma
  8400/1 | Sweat gland tumor, NOS
  8400/3 | Sweat gland adenocarcinoma
  8401/0 | Apocrine adenoma
  8401/3 | Apocrine adenocarcinoma
  8402/0 | Nodular hidradenoma
  8402/3 | Nodular hidradenoma, malignant
  8403/0 | Eccrine spiradenoma
  8403/3 | Malignant eccrine spiradenoma
  8404/0 | Hidrocystoma
  8405/0 | Papillary hidradenoma
  8406/0 | Papillary syringadenoma
  8407/0 | Syringoma, NOS
  8407/3 | Sclerosing sweat duct carcinoma
  8408/0 | Eccrine papillary adenoma
  8408/1 | Aggressive digital papillary adenoma
  8408/3 | Eccrine papillary adenocarcinoma
  8409/0 | Eccrine poroma
  8409/3 | Eccrine poroma, malignant
  8410/0 | Sebaceous adenoma
  8410/3 | Sebaceous adenocarcinoma
  8413/3 | Eccrine adenocarcinoma
  8420/0 | Ceruminous adenoma
  8420/3 | Ceruminous adenocarcinoma
  8430/1 | Mucoepidermoid tumor
  8430/3 | Mucoepidermoid carcinoma
  8440/0 | Cystadenoma, NOS
  8440/3 | Cystadenocarcinoma, NOS
  8441/0 | Serous cystadenoma, NOS
  8441/3 | Serous cystadenocarcinoma, NOS
  8442/1 | Serous cystadenoma, borderline malignancy
  8443/0 | Clear cell cystadenoma
  8444/1 | Clear cell cystic tumor of borderline malignancy
  8450/0 | Papillary cystadenoma, NOS
  8450/3 | Papillary cystadenocarcinoma, NOS
  8451/1 | Papillary cystadenoma, borderline malignancy
  8452/1 | Solid pseudopapillary tumor
  8452/3 | Solid pseudopapillary carcinoma
  8453/0 | Intraductal papillary-mucinous adenoma
  8453/1 | Intraductal papillary-mucinous tumor with moderate dysplasia
  8453/2 | Intraductal papillary-mucinous carcinoma, non-invasive
  8453/3 | Intraductal papillary-mucinous carcinoma, invasive
  8454/0 | Cystic tumor of atrio-ventricular node
  8460/0 | Papillary serous cystadenoma, NOS
  8460/3 | Papillary serous cystadenocarcinoma
  8461/0 | Serous surface papilloma
  8461/3 | Serous surface papillary carcinoma
  8462/1 | Serous papillary cystic tumor of borderline malignancy
  8463/1 | Serous surface papillary tumor of borderline malignancy
  8470/0 | Mucinous cystadenoma, NOS
  8470/1 | Mucinous cystic tumor with moderate dysplasia
  8470/2 | Mucinous cystadenocarcinoma, non-invasive
  8470/3 | Mucinous cystadenocarcinoma, NOS
  8471/0 | Papillary mucinous cystadenoma, NOS
  8471/3 | Papillary mucinous cystadenocarcinoma
  8472/1 | Mucinous cystic tumor of borderline malignancy
  8473/1 | Papillary mucinous cystadenoma, borderline malignancy
  8480/0 | Mucinous adenoma
  8480/3 | Mucinous adenocarcinoma
  8480/6 | Pseudomyxoma peritonei
  8481/3 | Mucin-producing adenocarcinoma
  8482/3 | Mucinous adenocarcinoma, endocervical type
  8490/3 | Signet ring cell carcinoma
  8490/6 | Metastatic signet ring cell carcinoma
  8500/2 | Intraductal carcinoma, noninfiltrating, NOS
  8500/3 | Infiltrating duct carcinoma, NOS
  8501/2 | Comedocarcinoma, noninfiltrating
  8501/3 | Comedocarcinoma, NOS
  8502/3 | Secretory carcinoma of breast
  8503/0 | Intraductal papilloma
  8503/2 | Noninfiltrating intraductal papillary adenocarcinoma
  8503/3 | Intraductal papillary adenocarcinoma with invasion
  8504/0 | Intracystic papillary adenoma
  8504/2 | Noninfiltrating intracystic carcinoma
  8504/3 | Intracystic carcinoma, NOS
  8505/0 | Intraductal papillomatosis, NOS
  8506/0 | Adenoma of nipple
  8507/2 | Intraductal micropapillary carcinoma
  8508/3 | Cystic hypersecretory carcinoma
  8510/3 | Medullary carcinoma, NOS
  8512/3 | Medullary carcinoma with lymphoid stroma
  8513/3 | Atypical medullary carcinoma
  8514/3 | Duct carcinoma, desmoplastic type
  8520/2 | Lobular carcinoma in situ, NOS
  8520/3 | Lobular carcinoma, NOS
  8851/0 | Fibrolipoma
  8851/3 | Liposarcoma, well differentiated
  8852/0 | Fibromyxolipoma
  8852/3 | Myxoid liposarcoma
  8853/3 | Round cell liposarcoma
  8854/0 | Pleomorphic lipoma
  8854/3 | Pleomorphic liposarcoma
  8855/3 | Mixed liposarcoma
  8856/0 | Intramuscular lipoma
  8857/0 | Spindle cell lipoma
  8857/3 | Fibroblastic liposarcoma
  8858/3 | Dedifferentiated liposarcoma
  8860/0 | Angiomyolipoma
  8861/0 | Angiolipoma, NOS
  8862/0 | Chondroid lipoma
  8870/0 | Myelolipoma
  8880/0 | Hibernoma
  8881/0 | Lipoblastomatosis
  8890/0 | Leiomyoma, NOS
  8890/1 | Leiomyomatosis, NOS
  8890/3 | Leiomyosarcoma, NOS
  8891/0 | Epithelioid leiomyoma
  8891/3 | Epithelioid leiomyosarcoma
  8892/0 | Cellular leiomyoma
  8893/0 | Bizarre leiomyoma
  8894/0 | Angiomyoma
  8894/3 | Angiomyosarcoma
  8895/0 | Myoma
  8895/3 | Myosarcoma
  8896/3 | Myxoid leiomyosarcoma
  8897/1 | Smooth muscle tumor of uncertain malignant potential
  8898/1 | Metastasizing leiomyoma
  8900/0 | Rhabdomyoma, NOS
  8900/3 | Rhabdomyosarcoma, NOS
  8901/3 | Pleomorphic rhabdomyosarcoma, adult type
  8902/3 | Mixed type rhabdomyosarcoma
  8903/0 | Fetal rhabdomyoma
  8904/0 | Adult rhabdomyoma
  8905/0 | Genital rhabdomyoma
  8910/3 | Embryonal rhabdomyosarcoma, NOS
  8912/3 | Spindle cell rhabdomyosarcoma
  8920/3 | Alveolar rhabdomyosarcoma
  8921/3 | Rhabdomyosarcoma with ganglionic differentiation
  8930/0 | Endometrial stromal nodule
  8930/3 | Endometrial stromal sarcoma, NOS
  8931/3 | Endometrial stromal sarcoma, low grade
  8932/0 | Adenomyoma
  8933/3 | Adenosarcoma
  8934/3 | Carcinofibroma
  8935/0 | Stromal tumor, benign
  8935/1 | Stromal tumor, NOS
  8935/3 | Stromal sarcoma, NOS
  9300/0 | Adenomatoid odontogenic tumor
  9301/0 | Calcifying odontogenic cyst
  9302/0 | Odontogenic ghost cell tumor
  9310/0 | Ameloblastoma, NOS
  9310/3 | Ameloblastoma, malignant
  9311/0 | Odontoameloblastoma
  9312/0 | Squamous odontogenic tumor
  9320/0 | Odontogenic myxoma
  9321/0 | Central odontogenic fibroma
  9322/0 | Peripheral odontogenic fibroma
  9330/0 | Ameloblastic fibroma
  9330/3 | Ameloblastic fibrosarcoma
  9340/0 | Calcifying epithelial odontogenic tumor
  9341/1 | Clear cell odontogenic tumor
  9342/3 | Odontogenic carcinosarcoma
  9350/1 | Craniopharyngioma
  9351/1 | Craniopharyngioma, adamantinomatous
  9352/1 | Craniopharyngioma, papillary
  9360/1 | Pinealoma
  9361/1 | Pineocytoma
  9362/3 | Pineoblastoma
  9363/0 | Melanotic neuroectodermal tumor
  9364/3 | Peripheral neuroectodermal tumor
  9365/3 | Askin tumor
  9370/3 | Chordoma, NOS
  9371/3 | Chondroid chordoma
  9372/3 | Dedifferentiated chordoma
  9373/0 | Parachordoma
  9380/3 | Glioma, malignant
  9381/3 | Gliomatosis cerebri
  9382/3 | Mixed glioma
  9383/1 | Subependymoma
  9384/1 | Subependymal giant cell astrocytoma
  9390/0 | Choroid plexus papilloma, NOS
  9390/1 | Atypical choroid plexus papilloma
  9390/3 | Choroid plexus carcinoma
  9391/3 | Ependymoma, NOS
  8521/3 | Infiltrating ductular carcinoma
  8522/2 | Intraductal carcinoma and lobular carcinoma in situ
  8522/3 | Infiltrating duct and lobular carcinoma
  8523/3 | Infiltrating duct mixed with other types of carcinoma
  8524/3 | Infiltrating lobular mixed with other types of carcinoma
  8525/3 | Polymorphous low grade adenocarcinoma
  8530/3 | Inflammatory carcinoma
  8540/3 | Paget disease, mammary
  8541/3 | Paget disease and infiltrating duct carcinoma of breast
  8542/3 | Paget disease, extramammary
  8543/3 | Paget disease and intraductal carcinoma of breast
  8550/0 | Acinar cell adenoma
  8550/1 | Acinar cell tumor
  8550/3 | Acinar cell carcinoma
  8551/3 | Acinar cell cystadenocarcinoma
  8560/0 | Mixed squamous cell and glandular papilloma
  8560/3 | Adenosquamous carcinoma
  8561/0 | Adenolymphoma
  8562/3 | Epithelial-myoepithelial carcinoma
  8570/3 | Adenocarcinoma with squamous metaplasia
  8571/3 | Adenocarcinoma with cartilaginous and osseous metaplasia
  8572/3 | Adenocarcinoma with spindle cell metaplasia
  8573/3 | Adenocarcinoma with apocrine metaplasia
  8574/3 | Adenocarcinoma with neuroendocrine differentiation
  8575/3 | Metaplastic carcinoma, NOS
  8576/3 | Hepatoid adenocarcinoma
  8580/0 | Thymoma, benign
  8580/1 | Thymoma, NOS
  8580/3 | Thymoma, malignant, NOS
  8581/1 | Thymoma, type A, NOS
  8581/3 | Thymoma, type A, malignant
  8582/1 | Thymoma, type AB, NOS
  8582/3 | Thymoma, type AB, malignant
  8583/1 | Thymoma, type B1, NOS
  8583/3 | Thymoma, type B1, malignant
  8584/1 | Thymoma, type B2, NOS
  8584/3 | Thymoma, type B2, malignant
  8585/1 | Thymoma, type B3, NOS
  8585/3 | Thymoma, type B3, malignant
  8586/3 | Thymic carcinoma, NOS
  8587/0 | Ectopic hamartomatous thymoma
  8588/3 | Spindle epithelial tumor with thymus-like element
  8589/3 | Carcinoma showing thymus-like element
  8590/1 | Sex cord-gonadal stromal tumor, NOS
  8591/1 | Sex cord-gonadal stromal tumor, incompletely differentiated
  8592/1 | Sex cord-gonadal stromal tumor, mixed forms
  8593/1 | Stromal tumor with minor sex cord elements
  8600/0 | Thecoma, NOS
  8600/3 | Thecoma, malignant
  8601/0 | Thecoma, luteinized
  8602/0 | Sclerosing stromal tumor
  8610/0 | Luteoma, NOS
  8620/1 | Granulosa cell tumor, adult type
  8620/3 | Granulosa cell tumor, malignant
  8621/1 | Granulosa cell-theca cell tumor
  8622/1 | Granulosa cell tumor, juvenile
  8623/1 | Sex cord tumor with annular tubules
  8630/0 | Androblastoma, benign
  8630/1 | Androblastoma, NOS
  8630/3 | Androblastoma, malignant
  8631/0 | Sertoli-Leydig cell tumor, well differentiated
  8631/1 | Sertoli-Leydig cell tumor of intermediate differentiation
  8631/3 | Sertoli-Leydig cell tumor, poorly differentiated
  8632/1 | Gynandroblastoma
  8633/1 | Sertoli-Leydig cell tumor, retiform
  8634/1 | Sertoli-Leydig cell tumor, intermediate differentiation, with heterologous elements
  8634/3 | Sertoli-Leydig cell tumor, poorly differentiated, with heterologous elements
  8640/1 | Sertoli cell tumor, NOS
  8640/3 | Sertoli cell carcinoma
  8641/0 | Sertoli cell tumor with lipid storage
  8642/1 | Large cell calcifying Sertoli cell tumor
  8650/0 | Leydig cell tumor, benign
  8650/1 | Leydig cell tumor, NOS
  8650/3 | Leydig cell tumor, malignant
  8660/0 | Hilus cell tumor
  8670/0 | Lipid cell tumor of ovary
  8670/3 | Steroid cell tumor, malignant
  8671/0 | Adrenal rest tumor
  8680/0 | Paraganglioma, benign
  8680/1 | Paraganglioma, NOS
  8680/3 | Paraganglioma, malignant
  8681/1 | Sympathetic paraganglioma
  8682/1 | Parasympathetic paraganglioma
  8683/0 | Gangliocytic paraganglioma
  8690/1 | Glomus jugulare tumor, NOS
  8691/1 | Aortic body tumor
  8692/1 | Carotid body tumor
  8693/1 | Extra-adrenal paraganglioma, NOS
  8693/3 | Extra-adrenal paraganglioma, malignant
  8700/0 | Pheochromocytoma, NOS
  8700/3 | Pheochromocytoma, malignant
  8710/3 | Glomangiosarcoma
  8711/0 | Glomus tumor, NOS
  8711/3 | Glomus tumor, malignant
  8712/0 | Glomangioma
  8713/0 | Glomangiomyoma
  8720/0 | Pigmented nevus, NOS
  8720/2 | Melanoma in situ
  8720/3 | Malignant melanoma, NOS
  8721/3 | Nodular melanoma
  8722/0 | Balloon cell nevus
  8722/3 | Balloon cell melanoma
  8723/0 | Halo nevus
  8723/3 | Malignant melanoma, regressing
  8725/0 | Neuronevus
  8726/0 | Magnocellular nevus
  8727/0 | Dysplastic nevus
  8728/0 | Diffuse melanocytosis
  8728/1 | Meningeal melanocytoma
  8728/3 | Meningeal melanomatosis
  8730/0 | Nonpigmented nevus
  8730/3 | Amelanotic melanoma
  8740/0 | Junctional nevus, NOS
  8740/3 | Malignant melanoma in junctional nevus
  8741/2 | Precancerous melanosis, NOS
  8741/3 | Malignant melanoma in precancerous melanosis
  8742/2 | Lentigo maligna
  8742/3 | Lentigo maligna melanoma
  8743/3 | Superficial spreading melanoma
  8744/3 | Acral lentiginous melanoma, malignant
  8745/3 | Desmoplastic melanoma, malignant
  8746/3 | Mucosal lentiginous melanoma
  8750/0 | Intradermal nevus
  8760/0 | Compound nevus
  8761/0 | Small congenital nevus
  8761/1 | Giant pigmented nevus, NOS
  8761/3 | Malignant melanoma in giant pigmented nevus
  8762/1 | Proliferative dermal lesion in congenital nevus
  8770/0 | Epithelioid and spindle cell nevus
  8770/3 | Mixed epithelioid and spindle cell melanoma
  8771/0 | Epithelioid cell nevus
  8771/3 | Epithelioid cell melanoma
  8772/0 | Spindle cell nevus, NOS
  8772/3 | Spindle cell melanoma, NOS
  8773/3 | Spindle cell melanoma, type A
  8774/3 | Spindle cell melanoma, type B
  8780/0 | Blue nevus, NOS
  8780/3 | Blue nevus, malignant
  8790/0 | Cellular blue nevus
  8800/0 | Soft tissue tumor, benign
  8800/3 | Sarcoma, NOS
  8800/9 | Sarcomatosis, NOS
  8801/3 | Spindle cell sarcoma
  8802/3 | Giant cell sarcoma
  8803/3 | Small cell sarcoma
  8804/3 | Epithelioid sarcoma
  8805/3 | Undifferentiated sarcoma
  8806/3 | Desmoplastic small round cell tumor
  8810/0 | Fibroma, NOS
  8810/1 | Cellular fibroma
  8810/3 | Fibrosarcoma, NOS
  8811/0 | Fibromyxoma
  8811/3 | Fibromyxosarcoma
  8812/0 | Periosteal fibroma
  8812/3 | Periosteal fibrosarcoma
  8813/0 | Fascial fibroma
  8813/3 | Fascial fibrosarcoma
  8814/3 | Infantile fibrosarcoma
  8815/0 | Solitary fibrous tumor
  8815/3 | Solitary fibrous tumor, malignant
  8820/0 | Elastofibroma
  8821/1 | Aggressive fibromatosis
  8822/1 | Abdominal fibromatosis
  8823/0 | Desmoplastic fibroma
  8824/0 | Myofibroma
  8824/1 | Myofibromatosis
  8825/0 | Myofibroblastoma
  8825/1 | Myofibroblastic tumor, NOS
  8826/0 | Angiomyofibroblastoma
  8827/1 | Myofibroblastic tumor, peribronchial
  8830/0 | Benign fibrous histiocytoma
  8830/1 | Atypical fibrous histiocytoma
  8830/3 | Malignant fibrous histiocytoma
  8831/0 | Histiocytoma, NOS
  8832/0 | Dermatofibroma, NOS
  8832/3 | Dermatofibrosarcoma, NOS
  8833/3 | Pigmented dermatofibrosarcoma protuberans
  8834/1 | Giant cell fibroblastoma
  8835/1 | Plexiform fibrohistiocytic tumor
  8836/1 | Angiomatoid fibrous histiocytoma
  8840/0 | Myxoma, NOS
  8840/3 | Myxosarcoma
  8841/1 | Angiomyxoma
  8842/0 | Ossifying fibromyxoid tumor
  8850/0 | Lipoma, NOS
  8850/1 | Atypical lipoma/j
  8850/3 | Liposarcoma, NOS
  8936/0 | Gastrointestinal stromal tumor, benign
  8936/1 | Gastrointestinal stromal tumor, NOS
  8936/3 | Gastrointestinal stromal sarcoma
  8940/0 | Pleomorphic adenoma
  8940/3 | Mixed tumor, malignant, NOS
  8941/3 | Carcinoma in pleomorphic adenoma
  8950/3 | Mullerian mixed tumor
  8951/3 | Mesodermal mixed tumor
  8959/0 | Benign cystic nephroma
  8959/1 | Cystic partially differentiated nephroblastoma
  8959/3 | Malignant cystic nephroma
  8960/1 | Mesoblastic nephroma
  8960/3 | Nephroblastoma, NOS
  8963/3 | Malignant rhabdoid tumor
  8964/3 | Clear cell sarcoma of kidney
  8965/0 | Nephrogenic adenofibroma
  8966/0 | Renomedullary interstitial cell tumor
  8967/0 | Ossifying renal tumor
  8970/3 | Hepatoblastoma
  8971/3 | Pancreatoblastoma
  8972/3 | Pulmonary blastoma
  8973/3 | Pleuropulmonary blastoma
  8974/1 | Sialoblastoma
  8980/3 | Carcinosarcoma, NOS
  8981/3 | Carcinosarcoma, embryonal
  8982/0 | Myoepithelioma
  8982/3 | Malignant myoepithelioma
  8983/0 | Adenomyoepithelioma
  8990/0 | Mesenchymoma, benign
  8990/1 | Mesenchymoma, NOS
  8990/3 | Mesenchymoma, malignant
  8991/3 | Embryonal sarcoma
  9000/0 | Brenner tumor, NOS
  9000/1 | Brenner tumor, borderline malignancy
  9000/3 | Brenner tumor, malignant
  9010/0 | Fibroadenoma, NOS
  9011/0 | Intracanalicular fibroadenoma
  9012/0 | Pericanalicular fibroadenoma
  9013/0 | Adenofibroma, NOS
  9014/0 | Serous adenofibroma, NOS
  9014/1 | Serous adenofibroma of borderline malignancy
  9014/3 | Serous adenocarcinofibroma
  9015/0 | Mucinous adenofibroma, NOS
  9015/1 | Mucinous adenofibroma of borderline malignancy
  9015/3 | Mucinous adenocarcinofibroma
  9016/0 | Giant fibroadenoma
  9020/0 | Phyllodes tumor, benign
  9020/1 | Phyllodes tumor, borderline
  9020/3 | Phyllodes tumor, malignant
  9030/0 | Juvenile fibroadenoma
  9040/0 | Synovioma, benign
  9040/3 | Synovial sarcoma, NOS
  9041/3 | Synovial sarcoma, spindle cell
  9042/3 | Synovial sarcoma, epithelioid cell
  9043/3 | Synovial sarcoma, biphasic
  9044/3 | Clear cell sarcoma, NOS
  9050/0 | Mesothelioma, benign
  9050/3 | Mesothelioma, malignant
  9051/0 | Fibrous mesothelioma, benign
  9051/3 | Fibrous mesothelioma, malignant
  9052/0 | Epithelioid mesothelioma, benign
  9052/3 | Epithelioid mesothelioma, malignant
  9053/3 | Mesothelioma, biphasic, malignant
  9054/0 | Adenomatoid tumor, NOS
  9055/0 | Multicystic mesothelioma, benign
  9055/1 | Cystic mesothelioma, NOS
  9060/3 | Dysgerminoma
  9061/3 | Seminoma, NOS
  9062/3 | Seminoma, anaplastic
  9063/3 | Spermatocytic seminoma
  9064/2 | Intratubular malignant germ cells
  9064/3 | Germinoma
  9065/3 | Germ cell tumor, nonseminomatous
  9070/3 | Embryonal carcinoma, NOS
  9071/3 | Yolk sac tumor
  9072/3 | Polyembryoma
  9073/1 | Gonadoblastoma
  9080/0 | Teratoma, benign
  9080/1 | Teratoma, NOS
  9080/3 | Teratoma, malignant, NOS
  9081/3 | Teratocarcinoma
  9082/3 | Malignant teratoma, undifferentiated
  9083/3 | Malignant teratoma, intermediate
  9084/0 | Dermoid cyst, NOS
  9084/3 | Teratoma with malignant transformation
  9085/3 | Mixed germ cell tumor
  9090/0 | Struma ovarii, NOS
  9090/3 | Struma ovarii, malignant
  9091/1 | Strumal carcinoid
  9100/0 | Hydatidiform mole, NOS
  9100/1 | Invasive hydatidiform mole
  9100/3 | Choriocarcinoma, NOS
  9101/3 | Choriocarcinoma combined with other germ cell elements
  9102/3 | Malignant teratoma, trophoblastic
  9103/0 | Partial hydatidiform mole
  9104/1 | Placental site trophoblastic tumor
  9105/3 | Trophoblastic tumor, epithelioid
  9110/0 | Mesonephroma, benign
  9110/1 | Mesonephric tumor, NOS
  9110/3 | Mesonephroma, malignant
  9120/0 | Hemangioma, NOS
  9120/3 | Hemangiosarcoma
  9121/0 | Cavernous hemangioma
  9122/0 | Venous hemangioma
  9123/0 | Racemose hemangioma
  9124/3 | Kupffer cell sarcoma
  9125/0 | Epithelioid hemangioma
  9130/0 | Hemangioendothelioma, benign
  9130/1 | Hemangioendothelioma, NOS
  9130/3 | Hemangioendothelioma, malignant
  9131/0 | Capillary hemangioma
  9132/0 | Intramuscular hemangioma
  9133/1 | Epithelioid hemangioendothelioma, NOS
  9133/3 | Epithelioid hemangioendothelioma, malignant
  9135/1 | Endovascular papillary angioendothelioma
  9136/1 | Spindle cell hemangioendothelioma
  9140/3 | Kaposi sarcoma
  9141/0 | Angiokeratoma
  9142/0 | Verrucous keratotic hemangioma
  9150/0 | Hemangiopericytoma, benign
  9150/1 | Hemangiopericytoma, NOS
  9150/3 | Hemangiopericytoma, malignant
  9160/0 | Angiofibroma, NOS
  9161/0 | Acquired tufted hemangioma
  9161/1 | Hemangioblastoma
  9170/0 | Lymphangioma, NOS
  9170/3 | Lymphangiosarcoma
  9171/0 | Capillary lymphangioma
  9172/0 | Cavernous lymphangioma
  9173/0 | Cystic lymphangioma
  9174/0 | Lymphangiomyoma
  9174/1 | Lymphangiomyomatosis
  9175/0 | Hemolymphangioma
  9180/0 | Osteoma, NOS
  9180/3 | Osteosarcoma, NOS
  9181/3 | Chondroblastic osteosarcoma
  9182/3 | Fibroblastic osteosarcoma
  9183/3 | Telangiectatic osteosarcoma
  9184/3 | Osteosarcoma in Paget disease of bone
  9185/3 | Small cell osteosarcoma
  9186/3 | Central osteosarcoma
  9187/3 | Intraosseous well differentiated osteosarcoma
  9191/0 | Osteoid osteoma, NOS
  9192/3 | Parosteal osteosarcoma
  9193/3 | Periosteal osteosarcoma
  9194/3 | High grade surface osteosarcoma
  9195/3 | Intracortical osteosarcoma
  9200/0 | Osteoblastoma, NOS
  9200/1 | Aggressive osteoblastoma
  9210/0 | Osteochondroma
  9210/1 | Osteochondromatosis, NOS
  9220/0 | Chondroma, NOS
  9220/1 | Chondromatosis, NOS
  9220/3 | Chondrosarcoma, NOS
  9221/0 | Juxtacortical chondroma
  9221/3 | Juxtacortical chondrosarcoma
  9230/0 | Chondroblastoma, NOS
  9230/3 | Chondroblastoma, malignant
  9231/3 | Myxoid chondrosarcoma
  9240/3 | Mesenchymal chondrosarcoma
  9241/0 | Chondromyxoid fibroma
  9242/3 | Clear cell chondrosarcoma
  9243/3 | Dedifferentiated chondrosarcoma
  9250/1 | Giant cell tumor of bone, NOS
  9250/3 | Giant cell tumor of bone, malignant
  9251/1 | Giant cell tumor of soft parts, NOS
  9251/3 | Malignant giant cell tumor of soft parts
  9252/0 | Tenosynovial giant cell tumor
  9252/3 | Malignant tenosynovial giant cell tumor
  9260/3 | Ewing sarcoma
  9261/3 | Adamantinoma of long bones
  9262/0 | Ossifying fibroma
  9270/0 | Odontogenic tumor, benign
  9270/1 | Odontogenic tumor, NOS
  9270/3 | Odontogenic tumor, malignant
  9271/0 | Ameloblastic fibrodentinoma
  9272/0 | Cementoma, NOS
  9273/0 | Cementoblastoma, benign
  9274/0 | Cementifying fibroma
  9275/0 | Gigantiform cementoma
  9280/0 | Odontoma, NOS
  9281/0 | Compound odontoma
  9282/0 | Complex odontoma
  9290/0 | Ameloblastic fibro-odontoma
  9290/3 | Ameloblastic odontosarcoma
  9392/3 | Ependymoma, anaplastic
  9393/3 | Papillary ependymoma
  9394/1 | Myxopapillary ependymoma
  9400/3 | Astrocytoma, NOS
  9401/3 | Astrocytoma, anaplastic
  9410/3 | Protoplasmic astrocytoma
  9411/3 | Gemistocytic astrocytoma
  9412/1 | Desmoplastic infantile astrocytoma
  9413/0 | Dysembryoplastic neuroepithelial tumor
  9420/3 | Fibrillary astrocytoma
  9421/1 | Pilocytic astrocytoma
  9423/3 | Polar spongioblastoma
  9424/3 | Pleomorphic xanthoastrocytoma
  9430/3 | Astroblastoma
  9440/3 | Glioblastoma, NOS
  9441/3 | Giant cell glioblastoma
  9442/1 | Gliofibroma
  9442/3 | Gliosarcoma
  9444/1 | Chordoid glioma
  9450/3 | Oligodendroglioma, NOS
  9451/3 | Oligodendroglioma, anaplastic
  9460/3 | Oligodendroblastoma
  9470/3 | Medulloblastoma, NOS
  9471/3 | Desmoplastic nodular medulloblastoma
  9472/3 | Medullomyoblastoma
  9473/3 | Primitive neuroectodermal tumor, NOS
  9474/3 | Large cell medulloblastoma
  9480/3 | Cerebellar sarcoma, NOS
  9490/0 | Ganglioneuroma
  9490/3 | Ganglioneuroblastoma
  9491/0 | Ganglioneuromatosis
  9492/0 | Gangliocytoma
  9493/0 | Dysplastic gangliocytoma of cerebellum (Lhermitte-Duclos)
  9500/3 | Neuroblastoma, NOS
  9501/0 | Medulloepithelioma, benign
  9501/3 | Medulloepithelioma, NOS
  9502/0 | Teratoid medulloepithelioma, benign
  9502/3 | Teratoid medulloepithelioma
  9503/3 | Neuroepithelioma, NOS
  9504/3 | Spongioneuroblastoma
  9505/1 | Ganglioglioma, NOS
  9505/3 | Ganglioglioma, anaplastic
  9506/1 | Central neurocytoma
  9507/0 | Pacinian tumor
  9508/3 | Atypical teratoid/rhabdoid tumor
  9510/0 | Retinocytoma
  9510/3 | Retinoblastoma, NOS
  9511/3 | Retinoblastoma, differentiated
  9512/3 | Retinoblastoma, undifferentiated
  9513/3 | Retinoblastoma, diffuse
  9514/1 | Retinoblastoma, spontaneously regressed
  9520/3 | Olfactory neurogenic tumor
  9521/3 | Olfactory neurocytoma
  9522/3 | Olfactory neuroblastoma
  9523/3 | Olfactory neuroepithelioma
  9530/0 | Meningioma, NOS
  9530/1 | Meningiomatosis, NOS
  9530/3 | Meningioma, malignant
  9531/0 | Meningothelial meningioma
  9532/0 | Fibrous meningioma
  9533/0 | Psammomatous meningioma
  9534/0 | Angiomatous meningioma
  9535/0 | Hemangioblastic meningioma
  9537/0 | Transitional meningioma
  9538/1 | Clear cell meningioma
  9538/3 | Papillary meningioma
  9539/1 | Atypical meningioma
  9539/3 | Meningeal sarcomatosis
  9540/0 | Neurofibroma, NOS
  9540/1 | Neurofibromatosis, NOS
  9540/3 | Malignant peripheral nerve sheath tumor
  9541/0 | Melanotic neurofibroma
  9550/0 | Plexiform neurofibroma
  9560/0 | Neurilemoma, NOS
  9560/1 | Neurinomatosis
  9560/3 | Neurilemoma, malignant
  9561/3 | Malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation
  9562/0 | Neurothekeoma
  9570/0 | Neuroma, NOS
  9571/0 | Perineurioma, NOS
  9571/3 | Perineurioma, malignant
  9580/0 | Granular cell tumor, NOS
  9580/3 | Granular cell tumor, malignant
  9581/3 | Alveolar soft part sarcoma
  9582/0 | Granular cell tumor of the sellar region
  9590/3 | Malignant lymphoma, NOS
  9591/3 | Malignant lymphoma, non-Hodgkin, NOS
  9596/3 | Composite Hodgkin and non-Hodgkin lymphoma
  9650/3 | Hodgkin lymphoma, NOS
  9651/3 | Hodgkin lymphoma, lymphocyte-rich
  9652/3 | Hodgkin lymphoma, mixed cellularity, NOS
  9653/3 | Hodgkin lymphoma, lymphocyte depletion, NOS
  9654/3 | Hodgkin lymphoma, lymphocyte depletion, diffuse fibrosis
  9655/3 | Hodgkin lymphoma, lymphocyte depletion, reticular
  9659/3 | Hodgkin lymphoma, nodular lymphocyte predominance
  9661/3 | Hodgkin granuloma
  9662/3 | Hodgkin sarcoma
  9663/3 | Hodgkin lymphoma, nodular sclerosis, NOS
  9664/3 | Hodgkin lymphoma, nodular sclerosis, cellular phase
  9665/3 | Hodgkin lymphoma, nodular sclerosis, grade 1
  9667/3 | Hodgkin lymphoma, nodular sclerosis, grade 2
  9670/3 | Malignant lymphoma, small B lymphocytic, NOS
  9671/3 | Malignant lymphoma, lymphoplasmacytic
  9673/3 | Mantle cell lymphoma
  9675/3 | Malignant lymphoma, mixed small and large cell, diffuse
  9678/3 | Primary effusion lymphoma
  9679/3 | Mediastinal large B-cell lymphoma
  9680/3 | Malignant lymphoma, large B-cell, diffuse, NOS
  9684/3 | Malignant lymphoma, large B-cell, diffuse, immunoblastic, NOS
  9687/3 | Burkitt lymphoma, NOS
  9689/3 | Splenic marginal zone B-cell lymphoma
  9690/3 | Follicular lymphoma, NOS
  9691/3 | Follicular lymphoma, grade 2
  9695/3 | Follicular lymphoma, grade 1
  9698/3 | Follicular lymphoma, grade 3
  9699/3 | Marginal zone B-cell lymphoma, NOS
  9700/3 | Mycosis fungoides
  9701/3 | Sezary syndrome
  9702/3 | Mature T-cell lymphoma, NOS
  9705/3 | Angioimmunoblastic T-cell lymphoma
  9708/3 | Subcutaneous panniculitis-like T-cell lymphoma
  9709/3 | Cutaneous T-cell lymphoma, NOS
  9714/3 | Anaplastic large cell lymphoma, T cell and Null cell type
  9716/3 | Hepatosplenic (gamma-delta) cell lymphoma
  9717/3 | Intestinal T-cell lymphoma
  9718/3 | Primary cutaneous CD30+ T-cell lymphoproliferative disorder
  9719/3 | NK/T-cell lymphoma, nasal and nasal-type
  9727/3 | Precursor cell lymphoblastic lymphoma, NOS
  9728/3 | Precursor B-cell lymphoblastic lymphoma
  9729/3 | Precursor T-cell lymphoblastic lymphoma
  9731/3 | Plasmacytoma, NOS
  9732/3 | Multiple myeloma
  9733/3 | Plasma cell leukemia
  9734/3 | Plasmacytoma, extramedullary (not occurring in bone)
  9740/1 | Mastocytoma, NOS
  9740/3 | Mast cell sarcoma
  9741/3 | Malignant mastocytosis
  9742/3 | Mast cell leukemia
  9750/3 | Malignant histiocytosis
  9751/1 | Langerhans cell histiocytosis, NOS
  9752/1 | Langerhans cell histiocytosis, unifocal
  9753/1 | Langerhans cell histiocytosis, multifocal
  9754/3 | Langerhans cell histiocytosis, disseminated
  9755/3 | Histiocytic sarcoma
  9756/3 | Langerhans cell sarcoma
  9757/3 | Interdigitating dendritic cell sarcoma
  9758/3 | Follicular dendritic cell sarcoma
  9760/3 | Immunoproliferative disease, NOS
  9761/3 | Waldenstrom macroglobulinemia
  9762/3 | Heavy chain disease, NOS
  9764/3 | Immunoproliferative small intestinal disease
  9765/1 | Monoclonal gammopathy of undetermined significance
  9766/1 | Angiocentric immunoproliferative lesion
  9767/1 | Angioimmunoblastic lymphadenopathy (AIC)
  9768/1 | T-gamma lymphoproliferative disease
  9769/1 | Immunoglobulin deposition disease
  9800/3 | Leukemia, NOS
  9801/3 | Acute leukemia, NOS
  9805/3 | Acute biphenotypic leukemia
  9820/3 | Lymphoid leukemia, NOS
  9823/3 | B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma
  9826/3 | Burkitt cell leukemia
  9827/3 | Adult T-cell leukemia/lymphoma (HTLV-1 positive)
  9831/3 | T-cell large granular lymphocytic leukemia
  9832/3 | Prolymphocytic leukemia, NOS
  9833/3 | Prolymphocytic leukemia, B-cell type
  9834/3 | Prolymphocytic leukemia, T-cell type
  9835/3 | Precursor cell lymphoblastic leukemia, NOS
  9836/3 | Precursor B-cell lymphoblastic leukemia
  9837/3 | Precursor T-cell lymphoblastic leukemia
  9840/3 | Acute myeloid leukemia, M6 type
  9860/3 | Myeloid leukemia, NOS
  9861/3 | Acute myeloid leukemia, NOS
  9863/3 | Chronic myeloid leukemia, NOS
  9866/3 | Acute promyelocytic leukemia
  9867/3 | Acute myelomonocytic leukemia
  9870/3 | Acute basophilic leukemia
  9871/3 | Acute myeloid leukemia with abnormal marrow eosinophils
  9872/3 | Acute myeloid leukemia, minimal differentiation
  9873/3 | Acute myeloid leukemia without maturation
  9874/3 | Acute myeloid leukemia with maturation
  9875/3 | Chronic myelogenous leukemia, BCR/ABL positive
  9876/3 | Atypical chronic myeloid leukemia, BCR/ABL negative
  9891/3 | Acute monocytic leukemia
  9895/3 | Acute myeloid leukemia with multilineage dysplasia
  9896/3 | Acute myeloid leukemia, t(8
  9897/3 | Acute myeloid leukemia, 11q23 abnormalities
  9910/3 | Acute megakaryoblastic leukemia
  9920/3 | Therapy-related acute myeloid leukemia, NOS
  9930/3 | Myeloid sarcoma
  9931/3 | Acute panmyelosis with myelofibrosis
  9940/3 | Hairy cell leukemia
  9945/3 | Chronic myelomonocytic leukemia, NOS
  9946/3 | Juvenile myelomonocytic leukemia
  9948/3 | Aggressive NK-cell leukemia
  9950/3 | Polycythemia vera
  9960/3 | Chronic myeloproliferative disease, NOS
  9961/3 | Myelosclerosis with myeloid metaplasia
  9962/3 | Essential thrombocythemia
  9963/3 | Chronic neutrophilic leukemia
  9964/3 | Hypereosinophilic syndrome
  9970/1 | Lymphoproliferative disorder, NOS
  9975/1 | Myeloproliferative disease, NOS
  9980/3 | Refractory anemia
  9982/3 | Refractory anemia with sideroblasts
  9983/3 | Refractory anemia with excess blasts
  9984/3 | Refractory anemia with excess blasts in transformation
  9985/3 | Refractory cytopenia with multilineage dysplasia
  9986/3 | Myelodysplastic syndrome with 5q deletion (5q-) syndrome
  9987/3 | Therapy-related myelodysplastic syndrome, NOS
  9989/3 | Myelodysplastic syndrome, NOS

### Expansion

ValueSet

Expansion based on code system fragment http://terminology.hl7.org/CodeSystem/icd-o-3 International Classification of Diseases for Oncology, version 3. version2000

Expansion from tx.fhir.org based on codesystem International Classification of Diseases for Oncology, version 3. version2000

Ce jeu de valeur (ValueSet) contient au moins 1 concepts

Code | Système | Display (en-US)
8500/3 | http://terminology.hl7.org/CodeSystem/icd-o-3 | Infiltrating duct carcinoma, NOS

Explanation of the columns that may appear on this page:

Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies
System | The source of the definition of the code (when the value set draws in codes defined elsewhere)
Code | The code (used as the code in the resource instance)
Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
Definition | An explanation of the meaning of the concept
Comments | Additional notes about how to use the code